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MATRIX BOUND FGF2 IN CARTILAGE
MECHANOTRANSDUCTION
T.L. Vincent, S-L. Chia, C. McLean, L. Full, J. Saklatvala
Kennedy Institute of Rheumatology, London, United Kingdom
Purpose: Background: Mechanical stimulation of articular carti-
lage is essential for normal joint maintenance and development,
as well as being a recognised risk factor in the development
of osteoarthritis. Whilst investigating the response of articular
cartilage to simple cutting and explantation, we observed the
release of a soluble factor which was a strong activator of the
extracellularly regulated kinase (ERK), one of the three mitogen
activated protein (MAP) kinases. This factor was identiﬁed by
mass spectrometry as basic FGF, also known as FGF2. We
subsequently showed that FGF2 activated ERK in chondrocytes
following cyclical loading, indicating that it mediated an important
tissue response after both injurious and non-injurious mechan-
ical stimuli. Using confocal microscopy and surface plasmon
resonance, we determined that FGF2 was bound to the heparan
sulphate chains of perlecan in the pericellular matrix of articular
cartilage, and that ERK activation upon loading was dependent
upon the concentration of pericellular FGF2.
Aim of the study: To determine the function of matrix bound
FGF2 in articular cartilage.
Methods: We studied the susceptibility of mice with and with-
out deletion of Fgf2 to cartilage degeneration with age, and
following surgical destabilisation of the medial meniscus. RNA
was extracted from joints of animals following surgery and PCR
performed to determine expression levels of key regulatory and
catabolic molecules. Hip explants from 4 week old mice were
stimulated in vitro with IL-1 +/- FGF2 and aggrecanolysis mea-
sured by DMMB and aggrecanase neoepitope assays.
Results: Fgf2-/- mice were morphologically indistinguishable
from wild-type animals and histomorphometric analysis at 3
months of age, revealed no differences in cartilage thickness
or intensity of proteoglycan staining. Nanoindentation studies by
atomic force microscopy showed no changes in the mechanical
properties of the tissue. Ageing studies did reveal accelerated
spontaneous cartilage degeneration in 6 and 9 month old animals
compared to wild type mice, and there was a signiﬁcant increase
in degeneration following surgical destabilisation of the medial
meniscus. Surgically-induced OA in Fgf2-/- mice was suppressed
to wild type levels by subcutaneous administration of recombinant
FGF2 indicating that FGF2 was acting as a chondroprotective
agent in mature articular cartilage.Increased disease in Fgf2-/-
mice was associated with increased expression of ADAMTS5, the
key murine aggrecanase, but not other matrix metalloproteinases
(MMPs), such as MMP13 and ADAMTS4. To test whether FGF2
was able to suppress ADAMTS5 expression in vitro, we stim-
ulated hip explants from wild type mice with interleukin-1. IL-1
induced aggrecanolysis and increased ADAMTS5 expression
which was suppressed by exogenous FGF2 by 50%.
Conclusions: These data identify FGF2 as a novel endogenous
inhibitor of aggrecan breakdown acting through suppression of
ADAMTS5. By inference, these data suggest that, through deliv-
ery of FGF2, joint loading is chondroprotective.
MENISCUS TEAR, MENISCECTOMY AND
OSTEOARTHRITIS – CAUSE OR CONSEQUENCE?
E.M. Roos
University of Southern Denmark, Odense, Denmark
Meniscectomy is the most frequent orthopaedic procedure, with
at least 450,000 procedures performed in the US yearly. Os-
teoarthritis (OA) follows meniscectomy in about every other pa-
tient after 10-15 years. OA development after meniscectomy is
thought to depend on the loss of meniscal function; i.e. shock
absorption and load transmission. This may constitute a major
cause of OA in the young patient with a meniscal tear in a
healthy knee. However, during the last decade emerging evi-
dence suggests that genetic factors and environment interact
and that meniscal tears often are a sign of incipient OA already
in the middle-aged. Intra-articular evidence includes meniscec-
tomized subjects having more OA also in the other knee and in
the hand, and MRI-veriﬁed meniscal tears being very common
in the elderly population. This has implications for our thinking of
OA prevention and for our treatment of meniscal tears.
Most patients do not recover as expected after meniscal surgery.
Although pain is relieved and self-reported function improved,
cross-sectional studies imply that patients do not reach the level
of matched controls or population-based samples, neither in the
immediate post-operative phase nor during the 20 years to come.
Pain, functional limitations and objectively assessed impaired
muscle function are features that post-meniscectomy patients
share with OA patients. Considering the role of pain and muscle
weakness as predictors of OA, these ﬁndings support that a
meniscal tear may signal OA and that patients with meniscal tear
may substantiate a suitable group for OA prevention.
A recent RCT indicated exercise alone being as effective as
meniscectomy and exercise in relieving pain and improving func-
tion in patients with an MRI veriﬁed meniscal tear. A previous
study of arthroscopic debridement (including removal of menis-
cal tears) compared to lavage and sham surgery showed no
beneﬁt of surgery in patients with early OA. We thus have to
question the effect of surgery for meniscal tears and other early
intra-articular signs of OA and consider alternative treatment
options. These options include evidence-based treatments such
as exercise (and weight-loss for the overweight) for patients with
meniscal tears in order to improve pain and function with min-
imal risk of side effects. These treatments might also delay or
prevent OA. Additional randomized trials are needed to further
document the efﬁcacy of currently practised treatments of these
patients.
MENISCUS MECHANICS, BIOLOGY AND
TRANSPLANTATION
P.C. Verdonk
Ghent University, Ghent, Belgium
Over the last few decades, the understanding of meniscal func-
tions and, consequently, the management of meniscal injuries,
has continued to evolve, with increasing commitment among
physicians to preserving the meniscus whenever possible. The
natural history of a meniscus-deﬁcient knee has been shown to
involve poor clinical and radiological outcomes over time, includ-
ing disruption of load-sharing and shock absorption, diminution
of joint stability, and deterioration of articular cartilage with pro-
gression to arthrosis.
The incongruency between the round femoral condyle and the
ﬂat tibial plateau is adapted by the meniscus. After removal of the
meniscus, the femorotibial contact area is largely reduced and
the peak stress on the articular cartilage considerably increased.
When confronted with an irreparable tear, substitution of the lost
tissue with a meniscus allograft or scaffold is gaining interest.
In order to improve our understanding of the meniscus function,
a better knowledge of the cellular biology of both the normal
meniscus as well as the transplanted meniscus is mandatory. Af-
ter all, the biomechanical behaviour of the meniscus (transplant)
is dictated by the cells residing within the tissue.
As more and more data is accumulated on the cells of the
normal meniscus, we now are aware that this ﬁbrocartilagenous
tissue has a unique architecture laid down by a number of
speciﬁc cells. Additionally, new insights are created based on
observations on cellular repopulation processes after meniscus
allograft transplantation. Better understanding the biomechanics
and biology of the meniscus should make us evolve towards a
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better treatment of the meniscus injury and should ideally halt
secondary articular cartilage degeneration.
DEVELOPMENT AND APPLICATION OF RESPONDER
CRITERIA, STATE-ATTAINMENTCRITERIA AND
NORMATIVE VALUES IN OSTEOARTHRITIS
N. Bellamy
University of Queensland, Brisbane, Australia
Purpose: Patient-centred self-reported measures provide op-
portunity, to evaluate the consequences of osteoarthritis that are
important and relevant to patients with the condition. The inter-
pretation of data from these measures is considerably enhanced
by criteria for response and state-attainment, and by normative
values for age and gender-matched individuals from the general
population.
Methods: In recent years several response deﬁnitions have
emerged. These include the OMERACT-OARSI Responder
Criteria, Minimum Perceptible Clinical Improvement (MPCI),
WOMAC 20-50-70 and Minimum Clinically Important Improve-
ment (MCII75). The MCII75 is a response criterion based on
the analysis of data from patients, questioned regarding their
perceptions of response following intervention.
More recently, several different deﬁnitions of state-attainment
have emerged. These include Patient Acceptable Symptom State
(PASS75), and the Bellamy et a Low Intensity Symptom State-
attainment (BLISS) Index. PASS75 is the 75th percentile of the
symptom severity score of patients who consider their health
state to be acceptable. In contrast, BLISS is deﬁned in terms
of magnitude, velocity and durability. Magnitude is classiﬁed by
normalised units (0-100nu) into the following categories: ? 25nu,
? 20nu, ? 15nu, ? 10nu and ? 5nu. Velocity is assessed in terms
of time to ﬁrst being in the state, while durability is evaluated
as follows: ever being in the state, in the state at termination,
number of study visits in the state and proportion of time spent
in the state.
An alternative method of benchmarking a patient’s health status,
is against normative values derived from standard questionnaire
items and estimated from surveys of the general population.
Returns from ∼13,000 individuals, in two studies targeting 60,000
members of the general public, have yielded age and gender-
speciﬁc estimates for items derived from the WOMAC≥ NRS 3.1
and AUSCAN NRS 3.1 Indices.
Results: MCII75 and PASS75 estimates differ for different coun-
tries and different types of OA The BLISS Index is capable
of detecting statistically signiﬁcant differences at near symp-
tom free levels. The normative data show important gender and
age-speciﬁc variation. To date, the majority of the responder
and state-attainment literature has concerned hip and knee OA.
However, preliminary investigation of the OARSI-OMERACT re-
sponder criteria, MCII75, AUSCAN 20-50-70, PASS75 and BLISS
Index, using the AUSCAN NRS 3.1 Index, suggests that these
concepts may also ﬁnd application in hand OA.
Conclusions: While further research is required, the concepts of
response and state-attainment are of vital importance in applying
quantitative measurement techniques in routine clinical practice,
and interpreting the clinical importance of clinical trials data.
The normative data are extremely valuable, as they provide
a benchmark for interpreting the patient’s health status in the
context of age and gender-matched peers.
HISTOPATHOLOGICALCRITERIA FOR EVALUATING OA
IN SMALL ANIMALS
A.M. Bendele
Bolder BioPATH, Boulder, CO
Purpose: Histopathology evaluation methods in the various small
animal OA models historically has been as diverse as the mod-
els themselves often resulting in confusion about how analysis
should be done and what features are important in determining
treatment effects of anti-arthritic agents.
In general, scoring systems for cartilage degeneration should
take into account depth and area affected by the important
changes (chondrocyte death, proteoglycan loss, collagen ﬁbrilla-
tion or loss) and should include as many measured (µm) rather
than subjectively scored parameters as possible. Zonal consid-
eration of lesion severity also aids in identifying areas of more
or less mechanical damage vs areas of more or less enzymatic
damage. Area of viable cartilage from surface to tidemark, ex-
cluding peripheral marginal zone changes and osteophytes, can
be measured by image analysis if sectioning is done in a consis-
tent manner. Similarly, cartilage thicknesses and depth of lesions
relative to thickness can be determined as can width of lesions
across surfaces. Osteophytes can be measured and thickness of
subchondral bone can be determined.
Although scoring and evaluation methods should be somewhat
tailored for the model and its morphologic features as well as type
of agent being evaluated, the above parameters can be applied
in most situations. One of the most critical features of any scoring
system beyond capturing relevant pathologies is that it be fairly
simple to understand and remember thus negating the need for
constant consultation of notes regarding what various numbers
equate to. This generally allows for less variability during data
collection and greater probability that different scientists will
arrive at the same conclusion.
This short discussion will focus on key parameters that have
proven to be useful for identifying treatment effects in various
models.
OARSI DEFINITION OF RADIOLOGICAL PROGRESSION
IN KNEE/HIP OSTEOARTHRITIS
M. Dougados
René descartes University, Paris, France
Purpose: The OARSI-OMERACT initiative aimed at providing a
set of criteria for considering Total Articular Replacement as end-
point for evaluating Disease Modifying Drugs for osteoarthritis is
ongoing.The steering committee of this intitiative has decided
that 3 kinds of information should be combined in such set of cri-
teria:1/level of pain, 2/level of functional impairment, and 3/level
of strucural damage. Concerning the structural damage, an ex-
haustive systematic litterature research together with evaluation
of different sets of X-Rays concluded that Joint Space Width
measured on plain X-Rays should be considered as the cur-
rent optimal technic (Gossec L. 2006 OARSI meeting). The still
remaining question was the deﬁnition of a relevant radiological
progression based on this evaluation.
Methods: Systematic Litterature Research combined with an
expert’s opinion approach
Results: The results will be presented during the OARSI meeting
Conclusions: This OARSI intiative should facilitate the conduct,
the analysis and the interpretation of studies/trials conducted in
knee/hip osteoarthritis
